It’s not too often we have a new insulin making its way on the scene, so we were excited to hear that Novo Nordisk filed two applications with the FDA for a new “ultra long acting” insulin called Degludec, and another for something called DegludecPlus, a combination of degludec and insulin aspart (Novolog), which would be available in an insulin pen in a fixed 70% degludec/30% Novolog ratio. The company is hoping for FDA approval…
Read more »
Health professionals reportedly are receiving letters this week alerting them to an FDA warning just issued about risks of thyroid cancer and pancreatitis associated with the popular type 2 diabetes drug liraglutide (Victoza). Yikes!
According to MSM reports, the evidence was found in mice, and it’s unclear if the serious risks translate to humans — but there was enough concern to issue the follow warning:
“Clinical trials have shown more cases of pancreatitis with liraglutide…
Read more »
For many parents and kids with diabetes, diabetes camp is a saving grace. When everyday life can leave you feeling isolated, diabetes camp provides a comradery and a normalcy to life with diabetes, along with your typical camp experience including arts and crafts, bonfires, late night bunk gossip, and lots of singing!
We bring this up now because it’s that time of year again when parents need to start thinking about signing kids up for…
Read more »
By
AmyT on
November 18, 2010
Talking to mainstream media about diabetes seems to be one of the biggest mysteries of life, does it not? When a big news story hits, we’re often faced with one perpetuated myth after another. For example, recent headlines screamed that the CDC is now speculating that 1 in 3 people in the US will have diabetes by 2050, but most stories didn’t specify that they meant type 2 diabetes exclusively. Big difference, right? Everyone from…
Read more »
By
AmyT on
September 23, 2010
Earlier this week, Novo Nordisk released results of a sweeping new survey about how patients — both type 1 and type 2 — struggle with insulin therapy, and what doctors accredit that to.
Entitled the Global Attitudes of Patients and Physicians in Insulin Therapy (GAPPTM), the survey was conducted among almost 3,000 physicians and patients in eight countries “with the objective to learn what they perceive to be the biggest functional and emotional unfulfilled needs…
Read more »
